Gene therapy means putting in a working gene to a person who has a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the product "Glybera" uses a virus to infect muscle cells with a working copy of the gene. The European Commission has given "Glybera" marketing authorisation, which means it can be sold throughout the EU.